Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Obesity HELP
Based on 86,842 articles since 2006
|||| 22 

These are the 86842 published articles about Obesity that originated from Worldwide during 2006-2015.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline ACOG Practice Bulletin No 156: Obesity in Pregnancy. 2015

Anonymous1050986. · ·Obstet Gynecol · Pubmed #26595582.

ABSTRACT: -- No abstract --

2 Guideline Obesity and reproduction: a committee opinion. 2015

Anonymous1930951. · ·Fertil Steril · Pubmed #26434804.

ABSTRACT: The purpose of this ASRM Practice Committee report is to provide clinicians with principles and strategies for the evaluation and treatment of couples with infertility associated with obesity. This revised document replaces the Practice Committee document titled, "Obesity and reproduction: an educational bulletin," last published in 2008 (Fertil Steril 2008;90:S21-9).

3 Guideline Danish clinical guidelines for examination and treatment of overweight and obese children and adolescents in a pediatric setting. 2015

Johansen, Anders / Holm, Jens-Christian / Pearson, Seija / Kjærsgaard, Mimi / Larsen, Lone Marie / Højgaard, Birgitte / Cortes, Dina / Anonymous2650964. ·Department of Growth and Reproduction, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark. anders.johansen.01@regionh.dk. · ·Dan Med J · Pubmed #26050836.

ABSTRACT: Overweight children are at an increased risk of becoming obese adults, which may lead to shorter life expectancies in the current generation of children as compared to their parents. Furthermore, being an overweight child has a negative psycho-social impact. We consider obesity in children and adolescents a chronic illness, which is in line with the American Medical Society. We summarize the evidence for the efficacy of a combination of diet, physical activity and behavior-focused interventions in a family-based setting. The present guidelines propose a multidisciplinary service implemented as a "chronic care model" based on "best clinical practice" inspired by an American expert committee and the daily practice of The Children's Obesity Clinic at Copenhagen University Hospital Holbaek. Children and adolescents should be referred for examination and treatment in a pediatric setting when BMI corresponds to an isoBMI of minimum 30 or BMI corresponds to an isoBMI of 25 and complex obesity is suspected. Obtaining a thorough medical history is pivotal. We propose a structured interview to ensure collection of all relevant information. We recommend physical examination focused on BMI, waist circumference, growth, pubertal stage, blood pressure, neurology and skin and provide comprehensive paraclinical investigations for obesity and obesity related conditions. Treatment of obesity in children and adolescents is fully dependent on the combined effort of the entire family. This cannot be overemphasized! The main principle of the treatment is developing an individual detailed plan for every patient to reduce caloric intake whilst increasing physical activity, leaving no ambiguity with the recommendations.

4 Guideline Peri-operative management of the obese surgical patient 2015: Association of Anaesthetists of Great Britain and Ireland Society for Obesity and Bariatric Anaesthesia. 2015

Anonymous5350966 / Nightingale, C E / Margarson, M P / Shearer, E / Redman, J W / Lucas, D N / Cousins, J M / Fox, W T A / Kennedy, N J / Venn, P J / Skues, M / Gabbott, D / Misra, U / Pandit, J J / Popat, M T / Griffiths, R / Anonymous5360966 / Anonymous5370966. · · Society for Obesity and Bariatric Anaesthesia. · Obstetric Anaesthetists' Association. · Royal College of Anaesthetists. · British Association of Day Surgery. · Resuscitation Council (UK). · Association of Anaesthetists of Great Britain & Ireland. · Difficult Airway Society. ·Anaesthesia · Pubmed #25950621.

ABSTRACT: Guidelines are presented for the organisational and clinical peri-operative management of anaesthesia and surgery for patients who are obese, along with a summary of the problems that obesity may cause peri-operatively. The advice presented is based on previously published advice, clinical studies and expert opinion.

5 Guideline Recommendations for growth monitoring, and prevention and management of overweight and obesity in children and youth in primary care. 2015

Anonymous300980. · ·CMAJ · Pubmed #25824498.

ABSTRACT: -- No abstract --

6 Guideline Standardized outcomes reporting in metabolic and bariatric surgery. 2015

Brethauer, Stacy A / Kim, Julie / El Chaar, Maher / Papasavas, Pavlos / Eisenberg, Dan / Rogers, Ann / Ballem, Naveen / Kligman, Mark / Kothari, Shanu / Anonymous670905. ·Bariatric and Metabolic Center, Digestive Disease Institute, Cleveland Clinic, 9500 Euclid Ave., M61, Cleveland, OH, 44195, USA, brethas@ccf.org. · ·Obes Surg · Pubmed #25802064.

ABSTRACT: -- No abstract --

7 Guideline The role of endoscopy in the bariatric surgery patient. 2015

Anonymous910947 / Evans, John A / Muthusamy, V Raman / Acosta, Ruben D / Bruining, David H / Chandrasekhara, Vinay / Chathadi, Krishnavel V / Eloubeidi, Mohamad A / Fanelli, Robert D / Faulx, Ashley L / Fonkalsrud, Lisa / Khashab, Mouen A / Lightdale, Jenifer R / Pasha, Shabana F / Saltzman, John R / Shaukat, Aasma / Wang, Amy / Stefanidis, Dimitrios / Richardson, William S / Kothari, Shanu N / Cash, Brooks D. · ·Gastrointest Endosc · Pubmed #25733126.

ABSTRACT: -- No abstract --

8 Guideline Pharmacological management of obesity: an endocrine Society clinical practice guideline. 2015

Apovian, Caroline M / Aronne, Louis J / Bessesen, Daniel H / McDonnell, Marie E / Murad, M Hassan / Pagotto, Uberto / Ryan, Donna H / Still, Christopher D / Anonymous1620804. ·Boston University School of Medicine and Boston Medical Center (C.M.A.), Boston, Massachusetts 02118; Weill-Cornell Medical College (L.J.A.), New York, New York 10065; Denver Health Medical Center (D.H.B.), Denver, Colorado 80204; Brigham and Women's Hospital (M.E.M.), Boston, Massachusetts 02115; Mayo Clinic, Division of Preventative Medicine (M.H.M.), Rochester, Minnesota 55905; Alma Mater University of Bologna (U.P.), S. Orsola-Malpighi Hospital Endocrinology Unit, 40138 Bologna, Italy; Pennington Biomedical Research Center (D.H.R.), Baton Rouge, Louisiana 70808; and Geisinger Health Care System (C.D.S.), Danville, Pennsylvania 17822. · ·J Clin Endocrinol Metab · Pubmed #25590212.

ABSTRACT: OBJECTIVE: To formulate clinical practice guidelines for the pharmacological management of obesity. PARTICIPANTS: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. This guideline was co-sponsored by the European Society of Endocrinology and The Obesity Society. EVIDENCE: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and the quality of evidence. CONSENSUS PROCESS: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the European Society of Endocrinology, and The Obesity Society reviewed and commented on preliminary drafts of these guidelines. Two systematic reviews were conducted to summarize some of the supporting evidence. CONCLUSIONS: Weight loss is a pathway to health improvement for patients with obesity-associated risk factors and comorbidities. Medications approved for chronic weight management can be useful adjuncts to lifestyle change for patients who have been unsuccessful with diet and exercise alone. Many medications commonly prescribed for diabetes, depression, and other chronic diseases have weight effects, either to promote weight gain or produce weight loss. Knowledgeable prescribing of medications, choosing whenever possible those with favorable weight profiles, can aid in the prevention and management of obesity and thus improve health.

9 Guideline (5) Prevention or delay of type 2 diabetes. 2015

Anonymous3860801. · ·Diabetes Care · Pubmed #25537704.

ABSTRACT: -- No abstract --

10 Guideline Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. 2014

Stegenga, Heather / Haines, Alexander / Jones, Katie / Wilding, John / Anonymous280797. ·National Collaborating Centre for Mental Health, Royal College of Psychiatrists, London, UK. · National Clinical Guideline Centre, Royal College of Physicians of London, London NW1 4LE, UK Alexander.Haines@rcplondon.ac.uk. · National Clinical Guideline Centre, Royal College of Physicians of London, London NW1 4LE, UK. · University of Liverpool and University Hospital Aintree, Liverpool, UK. · ·BMJ · Pubmed #25430558.

ABSTRACT: -- No abstract --

11 Guideline Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of eating disorders. 2014

Hay, Phillipa / Chinn, David / Forbes, David / Madden, Sloane / Newton, Richard / Sugenor, Lois / Touyz, Stephen / Ward, Warren / Anonymous360795. ·Members of the CPG Working Group School of Medicine and Centre for Health Research, University of Western Sydney, Australia School of Medicine, James Cook University, Townsville, Australia p.hay@uws.edu.au. · Members of the CPG Working Group Capital and Coast District Health Board, Wellington, New Zealand. · Members of the CPG Working Group School of Pediatrics and Child Health, University of Western Australia, Perth, Australia. · Members of the CPG Working Group Eating Disorders Service, Sydney Children's Hospital Network, Westmead, Australia; School of Psychiatry, University of Sydney, Australia. · Members of the CPG Working Group Mental Health CSU, Austin Health, Australia; University of Melbourne, Australia. · Members of the CPG Working Group Department of Psychological Medicine, University of Otago at Christchurch, New Zealand. · Members of the CPG Working Group School of Psychology and Centre for Eating and Dieting Disorders, University of Sydney, Australia. · Members of the CPG Working Group Eating Disorders Service Royal Brisbane and Women's Hospital; University of Queensland, Brisbane, Australia. · ·Aust N Z J Psychiatry · Pubmed #25351912.

ABSTRACT: OBJECTIVES: This clinical practice guideline for treatment of DSM-5 feeding and eating disorders was conducted as part of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Clinical Practice Guidelines (CPG) Project 2013-2014. METHODS: The CPG was developed in accordance with best practice according to the National Health and Medical Research Council of Australia. Literature of evidence for treatments of anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), other specified and unspecified eating disorders and avoidant restrictive food intake disorder (ARFID) was sourced from the previous RANZCP CPG reviews (dated to 2009) and updated with a systematic review (dated 2008-2013). A multidisciplinary working group wrote the draft CPG, which then underwent expert, community and stakeholder consultation, during which process additional evidence was identified. RESULTS: In AN the CPG recommends treatment as an outpatient or day patient in most instances (i.e. in the least restrictive environment), with hospital admission for those at risk of medical and/or psychological compromise. A multi-axial and collaborative approach is recommended, including consideration of nutritional, medical and psychological aspects, the use of family based therapies in younger people and specialist therapist-led manualised based psychological therapies in all age groups and that include longer-term follow-up. A harm minimisation approach is recommended in chronic AN. In BN and BED the CPG recommends an individual psychological therapy for which the best evidence is for therapist-led cognitive behavioural therapy (CBT). There is also a role for CBT adapted for internet delivery, or CBT in a non-specialist guided self-help form. Medications that may be helpful either as an adjunctive or alternative treatment option include an antidepressant, topiramate, or orlistat (the last for people with comorbid obesity). No specific treatment is recommended for ARFID as there are no trials to guide practice. CONCLUSIONS: Specific evidence based psychological and pharmacological treatments are recommended for most eating disorders but more trials are needed for specific therapies in AN, and research is urgently needed for all aspects of ARFID assessment and management. EXPERT REVIEWERS: Associate Professor Susan Byrne, Dr Angelica Claudino, Dr Anthea Fursland, Associate Professor Jennifer Gaudiani, Dr Susan Hart, Ms Gabriella Heruc, Associate Professor Michael Kohn, Dr Rick Kausman, Dr Sarah Maguire, Ms Peta Marks, Professor Janet Treasure and Mr Andrew Wallis.

12 Guideline Guidelines for laparoscopic peritoneal dialysis access surgery. 2014

Haggerty, Stephen / Roth, Scott / Walsh, Danielle / Stefanidis, Dimitrios / Price, Raymond / Fanelli, Robert D / Penner, Todd / Richardson, William / Anonymous3800794. ·Division of General Surgery, NorthShore University Healthsystem, Evanston, IL, USA, shaggerty@northshore.org. · ·Surg Endosc · Pubmed #25294537.

ABSTRACT: -- No abstract --

13 Guideline [Interdisciplinary European guidelines on metabolic and bariatric surgery]. 2014

Fried, M / Yumuk, V / Oppert, J M / Scopinaro, N / Torres, A / Weiner, R / Yashkov, Y / Frühbeck, G. · ·Rozhl Chir · Pubmed #25263472.

ABSTRACT: In 2012, an outstanding expert panel derived from IFSO-EC (International Federation for the Surgery of Obesity - European Chapter) and EASO (European Association for the Study of Obesity), composed by key representatives of both Societies including past and present presidents together with EASOs OMTF (Obesity Management Task Force) chair, agreed to devote the joint Medico-Surgical Workshop of both institutions to the topic of metabolic surgery as a pre-satellite of the 2013 European Congress on Obesity (ECO) to be held in Liverpool given the extraordinarily advancement made specifically in this field during the past years. It was further agreed to revise and update the 2008 Interdisciplinary European Guidelines on Surgery of Severe Obesity produced in cooperation of both Societies by focusing in particular on the evidence gathered in relation to the effects on diabetes during this lustrum and the subsequent changes that have taken place in patient eligibility criteria. The expert panel composition allowed the coverage of key disciplines in the comprehensive management of obesity and obesity-associated diseases, aimed specifically at updating the clinical guidelines to reflect current knowledge, expertise and evidence-based data on metabolic and bariatric surgery.

14 Guideline Nonsurgical management of urinary incontinence in women: a clinical practice guideline from the American College of Physicians. 2014

Qaseem, Amir / Dallas, Paul / Forciea, Mary Ann / Starkey, Melissa / Denberg, Thomas D / Shekelle, Paul / Anonymous4650791. · ·Ann Intern Med · Pubmed #25222388.

ABSTRACT: DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the nonsurgical management of urinary incontinence (UI) in women. METHODS: This guideline is based on published English-language literature on nonsurgical management of UI in women from 1990 through December 2013 that was identified using MEDLINE, the Cochrane Library, Scirus, and Google Scholar. The outcomes evaluated for this guideline include continence, improvement in UI, quality of life, adverse effects, and discontinuation due to adverse effects. It grades the evidence and recommendations by using ACP's guideline grading system. The target audience is all clinicians, and the target patient population is all women with UI. RECOMMENDATION 1: ACP recommends first-line treatment with pelvic floor muscle training in women with stress UI. (Grade: strong recommendation, high-quality evidence). RECOMMENDATION 2: ACP recommends bladder training in women with urgency UI. (Grade: strong recommendation, moderate-quality evidence). RECOMMENDATION 3: ACP recommends pelvic floor muscle training with bladder training in women with mixed UI. (Grade: strong recommendation, moderate-quality evidence). RECOMMENDATION 4: ACP recommends against treatment with systemic pharmacologic therapy for stress UI. (Grade: strong recommendation, low-quality evidence). RECOMMENDATION 5: ACP recommends pharmacologic treatment in women with urgency UI if bladder training was unsuccessful. Clinicians should base the choice of pharmacologic agents on tolerability, adverse effect profile, ease of use, and cost of medication. (Grade: strong recommendation, high-quality evidence). RECOMMENDATION 6: ACP recommends weight loss and exercise for obese women with UI. (Grade: strong recommendation, moderate-quality evidence).

15 Guideline Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. 2014

LeFevre, Michael L / Anonymous3420794. · ·Ann Intern Med · Pubmed #25155419.

ABSTRACT: DESCRIPTION: Update and refinement of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on dietary counseling for adults with risk factors for cardiovascular disease (CVD). METHODS: The USPSTF reviewed the evidence on whether primary care-relevant counseling interventions for a healthful diet and physical activity modify self-reported behaviors, intermediate physiologic outcomes, diabetes incidence, and cardiovascular morbidity or mortality in adults with CVD risk factors, as well as the adverse effects of counseling interventions. POPULATION: This recommendation applies to adults aged 18 years or older in primary care settings who are overweight or obese and have known CVD risk factors (hypertension, dyslipidemia, impaired fasting glucose, or the metabolic syndrome). RECOMMENDATION: The USPSTF recommends offering or referring adults who are overweight or obese and have additional CVD risk factors to intensive behavioral counseling interventions to promote a healthful diet and physical activity for CVD prevention. (B recommendation).

16 Guideline Children's Hospital Association consensus statements for comorbidities of childhood obesity. 2014

Estrada, Elizabeth / Eneli, Ihuoma / Hampl, Sarah / Mietus-Snyder, Michele / Mirza, Nazrat / Rhodes, Erinn / Sweeney, Brooke / Tinajero-Deck, Lydia / Woolford, Susan J / Pont, Stephen J / Anonymous870788. ·1 Division of Endocrinology, Connecticut Children's Medical Center, University of Connecticut , Hartford, CT. · ·Child Obes · Pubmed #25019404.

ABSTRACT: BACKGROUND: Childhood obesity and overweight affect approximately 30% of US children. Many of these children have obesity-related comorbidities, such as hypertension, dyslipidemia, fatty liver disease, diabetes, polycystic ovary syndrome (PCOS), sleep apnea, psychosocial problems, and others. These children need routine screening and, in many cases, treatment for these conditions. However, because primary care pediatric providers (PCPs) often are underequipped to deal with these comorbidities, they frequently refer these patients to subspecialists. However, as a result of the US pediatric subspecialist shortage and considering that 12.5 million children are obese, access to care by subspecialists is limited. The aim of this article is to provide accessible, user-friendly clinical consensus statements to facilitate the screening, interpretation of results, and early treatment for some of the most common childhood obesity comorbidities. METHODS: Members of the Children's Hospital Association (formerly NACHRI) FOCUS on a Fitter Future II (FFFII), a collaboration of 25 US pediatric obesity centers, used a combination of the best available evidence and collective clinical experience to develop consensus statements for pediatric obesity-related comorbidities. FFFII also surveyed the participating pediatric obesity centers regarding their current practices. RESULTS: The work group developed consensus statements for use in the evaluation and treatment of lipids, liver enzymes, and blood pressure abnormalities and PCOS in the child with overweight and obesity. The results of the FFFII survey illustrated the variability in the approach for initial evaluation and treatment as well as pattern of referrals to subspecialists among programs. CONCLUSIONS: The consensus statements presented in this article can be a useful tool for PCPs in the management and overall care of children with overweight and obesity.

17 Guideline Executive summary: Guidelines (2013) for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society published by the Obesity Society and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Based on a systematic review from the The Obesity Expert Panel, 2013. 2014

Anonymous7070784. · ·Obesity (Silver Spring) · Pubmed #24961825.

ABSTRACT: -- No abstract --

18 Guideline Reprint: 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. 2014

Anonymous1790783 / Anonymous1800783 / Anonymous1810783. · ·J Am Pharm Assoc (2003) · Pubmed #24898716.

ABSTRACT: -- No abstract --

19 Guideline European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. 2014

Parati, Gianfranco / Stergiou, George / O'Brien, Eoin / Asmar, Roland / Beilin, Lawrence / Bilo, Grzegorz / Clement, Denis / de la Sierra, Alejandro / de Leeuw, Peter / Dolan, Eamon / Fagard, Robert / Graves, John / Head, Geoffrey A / Imai, Yutaka / Kario, Kazuomi / Lurbe, Empar / Mallion, Jean-Michel / Mancia, Giuseppe / Mengden, Thomas / Myers, Martin / Ogedegbe, Gbenga / Ohkubo, Takayoshi / Omboni, Stefano / Palatini, Paolo / Redon, Josep / Ruilope, Luis M / Shennan, Andrew / Staessen, Jan A / vanMontfrans, Gert / Verdecchia, Paolo / Waeber, Bernard / Wang, Jiguang / Zanchetti, Alberto / Zhang, Yuqing / Anonymous3650785. ·aAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 bAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 cAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 dAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 eAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 fAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 gAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 hAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 iAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 jAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 kAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 lAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 mAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 nAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 oAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 pAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 qAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 rAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 sAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 tAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 uAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 vAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 wAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 xAuthor affiliations a · ·J Hypertens · Pubmed #24886823.

ABSTRACT: Given the increasing use of ambulatory blood pressure monitoring (ABPM) in both clinical practice and hypertension research, a group of scientists, participating in the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability, in year 2013 published a comprehensive position paper dealing with all aspects of the technique, based on the available scientific evidence for ABPM. The present work represents an updated schematic summary of the most important aspects related to the use of ABPM in daily practice, and is aimed at providing recommendations for proper use of this technique in a clinical setting by both specialists and practicing physicians. The present article details the requirements and the methodological issues to be addressed for using ABPM in clinical practice, The clinical indications for ABPM suggested by the available studies, among which white-coat phenomena, masked hypertension, and nocturnal hypertension, are outlined in detail, and the place of home measurement of blood pressure in relation to ABPM is discussed. The role of ABPM in pharmacological, epidemiological, and clinical research is also briefly mentioned. Finally, the implementation of ABPM in practice is considered in relation to the situation of different countries with regard to the reimbursement and the availability of ABPM in primary care practices, hospital clinics, and pharmacies.

20 Guideline [Guidelines of Sociedade Brasileira de Cardiologia for Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction (II Edition, 2007) 2013-2014 Update]. 2014

Nicolau, J C / Timerman, A / Marin-Neto, J A / Piegas, L S / Barbosa, C J D G / Franci, A / Avezum, A / Carvalho, A C C / Markman Filho, B / Polanczyk, C A / Rochitte, C E / Serrano Júnior, C V / Precoma, D B / Silva Junior, D G / Albuquerque, D C / Stefanini, E / Knobel, E / Jatene, F B / Feres, F / Morcerf, F A P / Ganem, F / Lima Filho, F A / Feitosa Filho, G S / Ferreira, J F M / Meneghetti, J C / Saraiva, J F K / Silva, L S / Maia, L N / Baracioli, L M / Lisboa, L A F / Dallan, L A O / Bodanese, L C / Andrade, M D / Oliveira Júnior, M / Dutra, O P / Coelho, O R / Leães, P E / Albuquerque, P F / Lemos, P / Kalil, R / Costa, R V C / Esporcate, R / Marino, R L / Botellho, R V / Meneghelo, R S / Sprovieri, S R / Timerman, S / Mathias Júnior, W / Anonymous2470782. · ·Arq Bras Cardiol · Pubmed #24862929.

ABSTRACT: -- No abstract --

21 Guideline The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. 2014

Conway, Gerard / Dewailly, Didier / Diamanti-Kandarakis, Evanthia / Escobar-Morreale, Héctor F / Franks, Stephen / Gambineri, Alessandra / Kelestimur, Fahrettin / Macut, Djuro / Micic, Dragan / Pasquali, Renato / Pfeifer, Marija / Pignatelli, Duarte / Pugeat, Michel / Yildiz, Bulent O / Anonymous1780791. ·Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey. · Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey renato.pasquali@unibo.it. · ·Eur J Endocrinol · Pubmed #24849517.

ABSTRACT: Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with androgen excess in women, which justifies the growing interest of endocrinologists. Great efforts have been made in the last 2 decades to define the syndrome. The presence of three different definitions for the diagnosis of PCOS reflects the phenotypic heterogeneity of the syndrome. Major criteria are required for the diagnosis, which in turn identifies different phenotypes according to the combination of different criteria. In addition, the relevant impact of metabolic issues, specifically insulin resistance and obesity, on the pathogenesis of PCOS, and the susceptibility to develop earlier than expected glucose intolerance states, including type 2 diabetes, has supported the notion that these aspects should be considered when defining the PCOS phenotype and planning potential therapeutic strategies in an affected subject. This paper offers a critical endocrine and European perspective on the debate on the definition of PCOS and summarises all major aspects related to aetiological factors, including early life events, potentially involved in the development of the disorder. Diagnostic tools of PCOS are also discussed, with emphasis on the laboratory evaluation of androgens and other potential biomarkers of ovarian and metabolic dysfunctions. We have also paid specific attention to the role of obesity, sleep disorders and neuropsychological aspects of PCOS and on the relevant pathogenetic aspects of cardiovascular risk factors. In addition, we have discussed how to target treatment choices based according to the phenotype and individual patient's needs. Finally, we have suggested potential areas of translational and clinical research for the future with specific emphasis on hormonal and metabolic aspects of PCOS.

22 Guideline [Non-alcoholic fatty liver: position document of the Catalan Society of Gastroenterology]. 2014

Caballería, Llorenç / Saló, Joan / Berzigotti, Annalisa / Planas, Ramón / Vila, Carme / Huertas, Carlos / Torres, Miquel / Torán, Pere / Caballería, Joan / Anonymous580784. ·Unitat de Suport a la Recerca (USR) Metropolitana Nord, IDIAP Jordi Gol, Barcelona, España; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, España. Electronic address: lcaballeria.bnm.ics@gencat.cat. · Servei de Digestiu, Consorci Hospitalari de Vic, Barcelona, España. · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, España; Laboratori d'Hemodinàmica Hepàtica, Unitat d'Hepatologia, Hospital Clínic, IDIBAPS, Barcelona, España. · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, España; Servei de Digestiu, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España. · Servicio Digestivo (Gastrodex), Hospital Universitario Quirón Dexeus, Barcelona, España. · Servei de Digestiu, Hospital Universitari Doctor Josep Trueta, Girona, España. · Servei de Medicina Interna, Fundació Hospital Esperit Sant, Santa Coloma de Gramenet, Barcelona, España. · Unitat de Suport a la Recerca (USR) Metropolitana Nord, IDIAP Jordi Gol, Barcelona, España; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, España. · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, España; Unitat d'Hepatologia, Hospital Clínic, IDIBAPS, Barcelona, España. · ·Gastroenterol Hepatol · Pubmed #24746904.

ABSTRACT: -- No abstract --

23 Guideline Clinical decisions in patients with diabetes and other cardiovascular risk factors. A statement of the Spanish Society of Internal Medicine. 2014

Gómez-Huelgas, R / Pérez-Jiménez, F / Serrano-Ríos, M / González-Santos, P / Román, P / Camafort, M / Conthe, P / García-Alegría, J / Guijarro, R / López-Miranda, J / Tirado-Miranda, R / Valdivielso, P / Anonymous5950779 / Anonymous5960779. ·Hospital Regional Universitario de Málaga, Internal Medicine Department, Málaga, Spain. Electronic address: ricardogomezhuelgas@hotmail.com. · Hospital Universitario Reina Sofia, Lipid and Atherosclerosis Unit, IMIBIC/Hospital Universitario Reina Sofia/Universidad de Cordoba, and CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Córdoba, Spain. · Hospital Clínico San Carlos, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Instituto de Investigacion (IdISSC), Madrid, Spain. · Hospital Clínico Universitario Virgen de la Victoria, Internal Medicine Service, Malaga, Spain. · Hospital General de Requena, Internal Medicine Department, Requena, Valencia, Spain. · Hospital Clinic IDIBAPS Universidad de Barcelona, Internal Medicine Department, Barcelona, Spain. · Hospital Gregorio Marañon, Internal Medicine Unit, Spain. · Hospital Costa del Sol, Internal Medicine Department, Autovia, Marbella, Málaga, Spain. · Hospital Regional Universitario Carlos Haya, Internal Medicine Unit, Malaga, Spain. · Hospital Infanta Margarita, Internal Medicine Department, Cabra, Cordoba, Spain. · Hospital Clínico Universitario Virgen de la Victoria, Internal Medicine Department, Malaga, Spain. · ·Rev Clin Esp (Barc) · Pubmed #24602600.

ABSTRACT: Although the mortality associated to cardiovascular diseases (CVD) has been reduced in the last decades, CVD remains the main cause of mortality in Spain and they are associated with an important morbidity and a huge economic burden. The increasing prevalence of obesity and diabetes could be slowing down the mortality reduction in Spain. Clinicians have often difficulty making clinical decisions due to the multiple clinical guidelines available. Moreover, in the current context of economic crisis it is critical to promote an efficient use of diagnostic and therapeutic proceedings to ensure the viability of public health care systems. The Spanish Society of Internal Medicine (SEMI) has coordinated a consensus document to answer questions of daily practice with the aim of facilitating physicians' decision-making in the management of diabetes and cardiovascular risk factors from a cost-efficiency point of view.

24 Guideline Committee opinion no. 591: challenges for overweight and obese women. 2014

Anonymous930774. · ·Obstet Gynecol · Pubmed #24553171.

ABSTRACT: Overweight and obesity are epidemic in the United States. Obesity is a risk factor for numerous conditions, including diabetes, hypertension, high cholesterol, stroke, heart disease, certain types of cancer, and arthritis. The prevalence of obesity is high, exceeding 30% in adult women and men. Many women, irrespective of demographic characteristics or income, are vulnerable to becoming overweight or obese because of limited resources for physical activity and healthy food choices, work commitments, and family demands. Clinicians and public health officials should address not only individual behavior but also the built environment in their efforts to reduce overweight and obesity in their patient populations.

25 Guideline 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. 2014

Jensen, Michael D / Ryan, Donna H / Apovian, Caroline M / Ard, Jamy D / Comuzzie, Anthony G / Donato, Karen A / Hu, Frank B / Hubbard, Van S / Jakicic, John M / Kushner, Robert F / Loria, Catherine M / Millen, Barbara E / Nonas, Cathy A / Pi-Sunyer, F Xavier / Stevens, June / Stevens, Victor J / Wadden, Thomas A / Wolfe, Bruce M / Yanovski, Susan Z / Anonymous960785 / Anonymous970785. · ·J Am Coll Cardiol · Pubmed #24239920.

ABSTRACT: -- No abstract --

Next